The global whole genome amplification market size surpassed USD 2,980 million in 2024 and is predicted to reach around USD 6,550 million by 2034, registering a CAGR of 8.2% from 2024 to 2034.
Whole-genome amplification is a widely used procedure in molecular biology, and oncology for studying mutations, which are involved in the formation of malignancies, and for the identification of the DNA, which may be left in trace at a criminal scene. It has become an essential tool in various scientific fields due to the possibility of raising the quantity of DNA specimens for research.
The need for whole genome amplification (WGA) has grown because of the increasing need for genetic data sampling as the task of identifying every gene in the human genome proceeds. These trends are expected to open up opportunities for the main market players. WGA kit and equipment manufacturers specialize in customized generation and convenient designs. This emphasis on usability is essential to growing the market penetration of WGA products.
Asia-Pacific whole genome amplification market is rising due to the rising applications of the polymerase chain reaction in research on genetic disorders and forensic services as well as advancements in the technologies section and the introduction of a new product by local participants in that area.
Published by Ajit Bansod
